ApoA-V(ab) Monoclonal Antibody

The protein encoded by this gene is an apolipoprotein that plays an important role in regulating the plasma triglyceride levels, a major risk factor for coronary artery disease. It is a component of high density lipoprotein and is highly similar to a rat protein that is upregulated in response to liver injury. Mutations in this gene have been associated with hypertriglyceridemia and hyperlipoproteinemia type 5. This gene is located proximal to the apolipoprotein gene cluster on chromosome 11q23. Alternatively spliced transcript variants encoding the same protein have been identified.

Introducing the APOA-V(AB) Monoclonal Antibody, a cutting-edge product designed to revolutionize the field of biomedical research. This highly specialized antibody is meticulously engineered to target and bind to the APOA-V protein, offering unprecedented accuracy and specificity in experimental applications.

Crafted with utmost precision, the APOA-V(AB) Monoclonal Antibody boasts an exceptional affinity for the APOA-V protein, enabling researchers to explore its intricate functions and unravel its role in various physiological processes. With its remarkable selectivity, this antibody ensures minimal cross-reactivity, guaranteeing reliable and reproducible results.

The APOA-V(AB) Monoclonal Antibody is meticulously manufactured using state-of-the-art techniques, adhering to stringent quality control measures. This ensures the utmost purity and consistency of the product, allowing researchers to confidently pursue their scientific inquiries with utmost confidence.

This groundbreaking antibody holds immense potential in elucidating the mechanisms underlying lipid metabolism, cardiovascular diseases, and other related disorders. Its unrivaled specificity and sensitivity make it an invaluable tool for studying APOA-V protein expression, localization, and interactions in various experimental models.

Furthermore, the APOA-V(AB) Monoclonal Antibody exhibits exceptional versatility, facilitating a wide range of applications including Western blotting, immunohistochemistry, immunofluorescence, and flow cytometry. Its compatibility with diverse experimental techniques empowers researchers to explore the APOA-V protein's involvement in different biological contexts.

In summary, the APOA-V(AB) Monoclonal Antibody represents a breakthrough in biomedical research, offering an unparalleled level of precision and reliability. With its exceptional specificity, purity, and versatility, this antibody is poised to revolutionize the understanding of APOA-V protein biology and pave the way for novel therapeutic interventions. Embrace the future of scientific exploration with the APOA-V(AB) Monoclonal Antibody.